m+Medelevator.RU
← Поиск публикаций
Research and practice in thrombosis and haemostasis · 2024

Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ward Chris, Curry Nicola, El-Ekiaby Magdy, Jurk Kerstin, Versteeg Henri H, Keragala Charithani, Burstyn-Cohen Tal, Antoniak Silvio, Suzuki Yuko, Baker Ross I, Christophe Olivier, Revel-Vilk Shoshana, Hart Alice, Deppermann Carsten, Tran Huyen, Pozzi Nicola, Kahr Walter H A, Grover Steven P, Wenzel Philip, Brown Ashley C, Oury Cécile, Shea Susan M, Fredenburgh James, Passam Freda H, Winearls James, Moore Hunter B, Tole Soumitra, Merriman Eileen, Barnes Geoffrey D, Liu Z Leonardo, Sholzberg Michelle

Аннотация

Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты